ID: hyp-SDA-2026-04-08-gap-pubmed-20260406-0
Hypothesis
Spinal Vascular Unit Breakdown as Universal Driver
Blood-spinal cord barrier breakdown represents mechanistic convergence point for diverse myelopathy etiologies, leading to stereotyped cascade of vascular dysfunction, protein extravasation, and secondary inflammation.
EvidencePending (0%)📖 5 cit🗣 1 debates✓ 5 support✗ 1 oppose
✓ All Quality Gates Passed
🧪 Overview
Blood-spinal cord barrier breakdown represents mechanistic convergence point for diverse myelopathy etiologies, leading to stereotyped cascade of vascular dysfunction, protein extravasation, and secondary inflammation.
🧬 Mechanism
🧬 Curated Mechanism Pathway
Curated pathway from expert analysis
flowchart TD
A["Diverse Spinal Cord Injury Triggers<br/>ALS Trauma Ischemia Compression"]
B["Spinal Vascular Unit Disruption<br/>Blood-Spinal Cord Barrier Breakdown"]
C["Pericyte Loss<br/>Endothelial Tight Junction Degradation"]
D["VEGFA Dysregulation<br/>Pro-Angiogenic Signaling Imbalance"]
E["Pathological Neovascularization<br/>Leaky Immature Vessel Formation"]
F["Serum Protein Extravasation<br/>Complement Albumin Fibrinogen Influx"]
G["Secondary Neuroinflammatory Cascade<br/>Universal Spinal Cord Pathology"]
H["Anti-VEGFA Combination Therapy<br/>Bevacizumab or Aflibercept"]
I["Vascular Stabilization<br/>Pericyte Coverage Restored"]
A --> B
B --> C
C --> D
D --> E
E --> F
F --> G
H -.->|"normalizes VEGFA"| D
H --> I
style D fill:#7b1fa2,stroke:#ce93d8,color:#ce93d8
style I fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7⚖️ Evidence
⚖️ Evidence Matrix5 supports0 contradicts
Supports
Biology and therapeutic targeting of vascular endothelial growth factor A.
Supports
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo.
Supports
Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription.
Supports
VEGFA mRNA-LNP promotes biliary epithelial cell-to-hepatocyte conversion in acute and chronic liver diseases and reverses steatosis and fibrosis.
Supports
VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk.
📖 Linked Papers
No linked papers recorded for this hypothesis yet.
🏥 Translation
🧬 3D Protein Structure — VEGFA
No curated PDB or AlphaFold mapping for VEGFA yet. Search RCSB →
💉 Clinical Trials
No clinical trials data linked to this hypothesis yet.
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for VEGFA.
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
🏆 Tournament
🏆 Arenas / Elo
No arena matches recorded yet. Browse Arenas →
📊 Market Indicators
7d Trend
↔
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0511
Events (7d)
0
Price History
▲5.2%💾 Resource Usage
LLM Tokens
12,040
$0.0722
Total Cost
$0.0722
▸Metadatasource: v1_phase_c_backfill · origin_type: debate_synthesis
| source | v1_phase_c_backfill |
| origin_type | debate_synthesis |
| _schema_version | 1 |
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting
0 contradicting
0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.